Autopsy report · NCT00295165
Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease
Cause of deathNo reason given
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 9 months before it stopped.
- 33 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Genzyme, a Sanofi Company
- Sponsor type
- Industry
- Conditions
- Crohn Disease
- Interventions
- Sargramostim (Leukine); Placebo
- Participants
- 33
- Sites
- 111
- Countries
- Australia, Brazil, Bulgaria, Canada, Israel, New Zealand, Romania, Russia, South Africa, Ukraine, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.